Background A survey of drug resistance-associated mutations (DRMs) was conducted in
2009 among 77 vertically HIV-infected children not treated by antiretroviral drugs, followed …

There is paucity of information on the prevalence of human immunodeficiency virus type 1
drug-resistance mutations in infants infected despite prevention of mother to child …

Objectives: We set out to examine the prevalence and persistence of mutations conferring
high-level nonnucleoside reverse transcriptase (NNRTI)-resistance in a cohort of HIV …

The acquisition of drug-resistance mutations among African children living with in human
immunodeficiency virus on antiretroviral treatment has been scarcely reported. This …

Background: There are limited data on primary human immunodeficiency virus drug
resistance (HIVDR) in pediatric populations. This study aimed to assess the prevalence of …

Objective: To describe the prevalence of HIV-1 drug resistance mutations at the time of
treatment initiation in a large cohort of HIV-infected children previously exposed to single …

ABSTRACT HIV-1 drug resistance testing in children and adolescents in low-resource
settings is both important and challenging. New (more sensitive) drug resistance testing …

Background Limited data are available on patterns of resistance mutations in pediatric
patients in southern Africa, where HIV-1 subtype C (HIV-1C) predominates. Methods …

Objectives In resource-limited settings, it is a challenge to get quality clinical specimens due
to poor infrastructure for their collection, transportation, processing and storage. Using dried …

Abstract Background Drug resistance mutations (DRMs) increasingly jeopardize paediatric
HIV programmes in sub-Saharan Africa. As individual monitoring of DRMs and viral loads …